Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis, 1873-5835

Journal

More filtering options
  1. 2020
  2. Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapy

    Stina Söderlund, Inger Persson, Mette Ilander, Joëlle Guilhot, Henrik Hjorth-Hansen, Perttu Koskenvesa, Johan Richter, Susanne Saussele, Satu Mustjoki & Ulla Olsson-Strömberg, 2020, In : Leukemia Research. 90, 106310.

    Research output: Contribution to journalArticle

  3. 2016
  4. Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli

    Stina Söderlund, Lisa Christiansson, Inger Persson, Henrik Hjorth-Hansen, Johan Richter, Bengt Simonsson, Satu Mustjoki, Ulla Olsson-Strömberg & Angelica Loskog, 2016 Nov 1, In : Leukemia Research. 50, p. 95-103 9 p.

    Research output: Contribution to journalArticle

  5. 2014
  6. Identification of B-cell lymphoma subsets by plasma protein profiling using recombinant antibody microarrays.

    Frida Pauly, Karin E Smedby, Mats Jerkeman, Henrik Hjalgrim, Mattias Ohlsson, Richard Rosenquist, Carl A K Borrebaeck & Christer Wingren, 2014, In : Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis. 38, 6, p. 682-690

    Research output: Contribution to journalArticle

  7. Minimizing risk of hypomethylating agent failure in patients with higher-risk MDS and practical management recommendations.

    Valeria Santini, Thomas Prebet, Pierre Fenaux, Norbert Gattermann, Lars Nilsson, Michael Pfeilstöcker, Paresh Vyas & Alan F List, 2014, In : Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis. 38, 12, p. 1381-1391

    Research output: Contribution to journalReview article

  8. 2013
  9. 2012
  10. Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12;21)(p13;q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol

    Gisela Barbany, Mette K. Andersen, Kirsti Autio, Georg Borgstrom, Lucia Cavalier Franco, Irina Golovleva, Sverre Heim, Kristina Heinonen, Randi Hovland, Bertil Johansson, Johann H. Johannsson, Eigil Kjeldsen, Ann Nordgren, Lars Palmqvist & Erik Forestier, 2012, In : Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis. 36, 7, p. 936-938

    Research output: Contribution to journalLetter

  11. Nucleolar proteins with altered expression in leukemic cell lines.

    Kaisa J Teittinen, Pauliina Kärkkäinen, Johanna Salonen, Gunilla Rönnholm, Hanna Korkeamäki, Mauno Vihinen, Nisse Kalkkinen & Olli Lohi, 2012, In : Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis. 36, 2, p. 232-236

    Research output: Contribution to journalArticle

  12. 2011
  13. TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia

    Norafiza Zainuddin, Fiona Murray, Meena Kanduri, Rebeqa Gunnarsson, Karin E. Smedby, Gunilla Enblad, Jesper Jurlander, Gunnar Juliusson & Richard Rosenquist, 2011, In : Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis. 35, 2, p. 272-274

    Research output: Contribution to journalArticle

Previous 1 2 3 Next